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Abstract To evaluate the promoter function of the 5P-flanking
sequence of mouse Q-sarcoglycan (Q-SG) gene in vivo, we
generated transgenic mice harboring this sequence fused with
enhanced green fluorescent protein reporter gene. The reporter
expression was restricted in striated muscles and particularly
strong in all myofibers in skeletal muscles. Using these mice, we
examine the spatial and temporal transcriptional patterns of the
Q-SG gene during mouse skeletal muscle development. The
expression of basic helix loop helix transcriptional factors
preceded that of the reporter. Differences between the expression
of reporter and endogenous Q-SG genes in non-muscle tissues
suggested the existence of additional promoter elements in the
endogenous gene, and the analysis of endogenous mRNAs
demonstrated the existence of a novel upstream exon and
promoter active in non-muscle tissues. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
In the skeletal muscle, the sarcoglycan (SG) complex con-
sists of four subunits, K-SG, L-SG, Q-SG and N-SG [1]. This
complex is present on the sarcolemma as a subcomplex of
dystrophin and its associated protein complex [2,3]. The
gene for each of these SG subunits is responsible for autoso-
mal recessive muscular dystrophy, sarcoglycanopathy [4]. Mu-
tation of any one gene encoding an SG subunit results in
sarcoglycanopathy in which all other SG subunits on the sar-
colemma are lost or greatly reduced in amount. Thus for the
presence of the SG complex on the sarcolemma, it is required
that all SG subunits be normally expressed.
Previously, we analyzed the expression of SG gene prod-
ucts, transcripts and proteins, during myotube di¡erentiation
in the mouse skeletal muscle C2C12 cell line [5]. In proliferat-
ing myoblasts, all SG transcripts were expressed at approxi-
mately equal levels. After myotube formation, the level of K-
SG and Q-SG transcripts selectively increased, while L-SG and
N-SG remain unchanged. This transcriptional upregulation of
the K-SG and Q-SG genes seems to trigger the SG complex
formation because all the SG proteins accumulated almost
immediately after myotube formation [6]. For the elucidation
of the SG complex formation process, not only the SG sub-
unit assembly in the post-translational step, but also the reg-
ulation of SG gene expression should be analyzed. Thus, we
recently isolated the promoters of four mouse SG genes and
analyzed their transcriptional regulation using the C2C12 cell
line [7]. We identi¢ed a basal promoter region and two en-
hancer regions in the Q-SG promoter. Furthermore, in the
upstream enhancer, we found A/T-rich and E-box elements,
which are essential for transcriptional activation during my-
ocyte di¡erentiation.
In this study, using transgenic mice harboring a reporter
gene fused with the 5P-£anking sequence of the Q-SG gene,
we examined the promoter activity of this sequence in vivo
by analyzing the spatial, temporal, and tissue-speci¢c expres-
sion patterns of the transgene during mouse development. We
found that this promoter region is su⁄cient to direct a strong
expression in vivo in the skeletal muscle and also showed that
this expression could reproduce the transcriptional pattern of
the endogenous Q-SG gene during skeletal muscle develop-
ment.
2. Materials and methods
2.1. Generation of transgenic mouse
The transgene vector was constructed by insertion of the rabbit L-
globin intron 2 sequence and SV40 polyA site derived from plasmid
pBstN [8], at the 3P-end of an enhanced green £uorescence protein
(EGFP, Clontech) sequence in a 5Pgsg-EGFP plasmid [7]. The 5Pgsg-
EGFP plasmid contains a 1.5-kbp 5P-£anking sequence extending
from 31458 to +21 relative to the transcription initiation site (+1)
of the mouse Q-SG gene, and a coding sequence for EGFP. The 5.0-
kbp fragment was cut out from the vector with NotI and HindIII, and
puri¢ed by agarose gel electrophoresis. The transgenic mice were gen-
erated by microinjection of this fragment into pronuclei of fertilized
eggs of C57BL/6J mice. Transgenic animals were identi¢ed by PCR
ampli¢cation or Southern blot analysis of tail DNA. The founder
mice were crossed with C57BL/6J mice to produce transgenic progeny.
All animal handling procedures were in accordance with a protocol
approved by the National Institute of Neuroscience, NCNP, Japan.
2.2. Reverse transcription-PCR (RT-PCR)
Total RNA from various tissues of the adult transgenic mice was
prepared with Trizol (Gibco BRL). Primer pairs for endogenous Q-SG
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and G3PDH transcripts in RT-PCR were used as reported previously
[5]. Reverse transcription reaction was carried out using 1 Wg of total
RNA with AMV Reverse transcriptase XL (Takara) at 55‡C for 30
min. Ampli¢cation was carried out using LA-Taq (Takara) for 30
cycles, each cycle consisting of 94‡C for 30 s, 65‡C for 5 min. Primer
pairs AATAACCAGCACGTTGCCCAGGAG (antisense primer),
GGTGGTGCCCATCCTGGTCGAG (sense primer) for the 5Pgsg-
EGFP transgene, and GCGCTTCCTCCATCCGTAAATGCC (anti-
sense primer), GTCAGGGACCGCTCCACCTGGAGC (sense prim-
er) for brain-speci¢c transcript of Q-SG were used. 5P-End sequences
of Q-SG transcripts were examined by the rapid ampli¢cation of
cDNA ends (RACE) method as described previously [7].
2.3. Observation of EGFP
Mouse embryos were dissected by removing the entire covering
including the amnion, and then ¢xed in 2% paraformaldehyde for
120 min at 4‡C. For observation of a 9.5-dpc (days post-coitum)
whole embryo, or forelimb buds and hindlimb buds from 10.5-dpc
to 13.5-dpc mice, ¢xed samples were washed with phosphate-bu¡ered
saline (PBS) and mounted on a glass slide in PBS containing 80%
glycerol. For preparation of cryosections of embryos and neonatal
mouse hearts, the ¢xed samples were immersed in PBS containing
25% sucrose for 1 day, then embedded in OCT compound (Miles)
and frozen. Muscle cryosections from adult mice were prepared as
described previously [9]. EGFP £uorescence in the embryos and their
sections were observed under a Leica TCS SP confocal laser micro-
scope (Leica). To visualize the 9.5-dpc embryo and isolated limbs,
spontaneous £uorescence was also observed with a high sensitivity
at tetramethyl rhodamine excitation (530 nm) and emission (590
nm) wavelength separated with a prism. Three-dimensional £uores-
cence images of limbs were reconstructed from two-dimensional scan-
ning images using a Leica TCS-NT program. Polyclonal antibodies
against Myf-5 (C-20), MyoD (M-20) and myogenin (C-12) were pur-
chased from Santa Cruz Biotechnology.
2.4. In situ hybridization
In situ hybridization was performed according to the method of
Hatanaka and Jones [10] using cRNA probes described previously [5].
2.5. Preparation and culture of primary myocytes
Primary myocytes were isolated from hindlimbs of neonatal trans-
genic mice and cultured as reported by Hagiwara and Ozawa [11]. On
the second day after plating the cells, di¡erentiation was induced by
changing the medium to Dulbecco’s modi¢ed Eagle’s medium con-
taining 1 mM hydroxylurea in 5% horse serum.
3. Results and discussion
3.1. Tissue-speci¢c expression pattern of the transgene
We generated transgenic mice harboring the transgene
5Pgsg-EGFP, which contains the 1.5-kbp mouse Q-SG pro-
moter sequence and the EGFP coding sequence as a reporter
gene. Two transgenic mouse lines (#59 and #66) expressing
EGFP from ¢ve independent lines were used in this study. At
¢rst, we analyzed the transcription of the transgene in various
tissues of adult F1 mice by RT-PCR (Fig. 1A). The endoge-
nous Q-SG transcript was detected in abundance in the skeletal
muscle of the limbs, diaphragm and heart as shown by North-
ern blotting which was described previously in human tissues
[4] and examined in mouse tissues (data not shown). Other
than these tissues, it was weakly detected by RT-PCR in the
cerebellum, olfactory bulb, spinal cord, skin, lung, aorta and
testis. Recently, the expression of the Q-SG transcript in the
lung was reported by Durbeej and Campbell [12]. On the
other hand, the 5Pgsg-EGFP transcript had a more restricted
distribution than the endogenous Q-SG transcript. The 5Pgsg-
EGFP transcript was detected in abundance in the skeletal
muscle of the limbs, diaphragm, at a moderate level in the
heart and at low levels in the spinal cord and testis, but not in
the cerebellum, olfactory bulb, aorta and lung. From our
examination, the mice of transgenic lines #59 and #66 exhib-
ited entirely the same pattern of tissue distribution. To exam-
ine this di¡erence between transgene and endogenous tran-
scripts, we analyzed 5P-ends of the Q-SG transcripts in the
skeletal muscle, heart, cerebellum, and lung by RACE. In
the skeletal muscle and heart, the products containing only
muscle-type exon (ME) 1 were obtained shown as (1) and (2)
shown in Fig. 1B. No ampli¢ed product was obtained from
lung RNA. In the cerebellum, a novel 5P-sequence (310 bp,
GenBank/EMBL/DDBJ accession no. AB056897), linked to
ME3 sequence was identi¢ed ((3) in Fig. 1B). This sequence
may be included in a single exon (brain-type exon 1: BE1),
because PCR ampli¢cation with the primer pairs derived from
5P- and 3P-ends of this novel sequence gave a product from
genomic DNA whose sequence completely matched the se-
quence obtained by RACE. Using a sense primer from BE1
and an antisense primer from ME3, we surveyed the use of
this BE1 in eight tissues by RT-PCR as indicated in Fig. 1C.
Two bands were ampli¢ed in RNA only from the olfactory
bulb and cerebellum (lanes O and C). A larger product (475
bp) contains ME1 as exon 2 while a shorter (320 bp) one does
not, shown as (4) and (3), respectively, in Fig. 1B. These
Fig. 1. Tissue-speci¢c and spatial expression of 5Pgsg-EGFP trans-
gene. A: RT-PCR was carried out for the transcripts of 5Pgsg-
EGFP transgene (5Pgsg-EGFP), endogenous Q-SG (Q-SG), and
G3PDH as a control. The skeletal muscle sample was isolated from
limbs. B and C: Identi¢cation of the brain-speci¢c exon in Q-SG
transcripts. B: 5P-Regions of muscle-type transcripts (1), (2) and
brain-type transcripts (3), (4) are illustrated under Q-SG genomic
con¢guration with intron sizes (kbp); muscle-type exon 1 (ME1),
exon 2 (ME2) and exon 3 (ME3) were mapped as reported previ-
ously [7]. Transcripts (1) and (2) in the skeletal muscle (M), (2) in
the heart (H) and (3) in the cerebellum (C) were isolated by RACE.
BE1, brain-type exon 1. C: 5P-Region of the brain-type transcript
was ampli¢ed by RT-PCR from RNA in various Q-SG-expressing
tissues using antisense primer from BE1 and sense primer from
ME3. The larger (475 bp) and shorter (320 bp) bands from cerebel-
lum and olfactory bulb correspond to (4) and (3) in B, respectively.
D, diaphragm; H, heart; T, testis; S, spinal cord; O, olfactory
bulb; C, cerebellum; M, skeletal muscle; L, lung.
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results suggest that Q-SG gene is transcribed in these two tis-
sues using another promoter located upstream of the muscle-
type promoter.
3.2. Spatial expression pattern of the transgene in 15.5-dpc
embryo
We used £uorescence microscopy to analyze the EGFP lo-
calization in the transgene-expressing tissues in adult and neo-
natal mice. Transgenic mouse lines #59 and #66 exhibited
entirely the same patterns for EGFP expression in skeletal
muscles. EGFP was strongly expressed in all myo¢bers in
the skeletal muscle of the limbs and diaphragm (Fig. 2A,B).
No di¡erence in £uorescence strength was observed in the fast
and slow ¢bers (data not shown). This suggests that the 1.5-
kbp region (31458 to +12) of the Q-SG promoter is su⁄cient
to highly promote transcription in all types of skeletal muscle
cells. In the heart, the number and distribution of the EGFP-
expressing cells were variable in individual transgenic mice
even if they were of the same line. Fig. 2C shows the heart
section from the #66 transgenic mouse where EGFP was
strongly expressed in nearly half of the myocardia in the right
ventricle and also in small parts in the left ventricle and in-
terventricular septum. We failed to detect EGFP in the spinal
cord and testis. It was also not detected in the peripheral
nerve, consistent with our previous report that O-SG contain-
ing the SG complex found in the peripheral nerve does not
have Q-SG [8].
We analyzed spatial expression patterns of the transgene in
parasagittal and midsagittal sections (Fig. 2D,E, respectively)
of the 15.5-dpc embryo. The EGFP was localized in the entire
body speci¢cally in the skeletal muscles, such as the extrinsic
ocular muscle, back muscle, pectoral muscle, intercostal
Fig. 2. Spatial expression of 5Pgsg-EGFP transgene. A^C: The lo-
calization of reporter EGFP in cryosections from quadriceps muscle
(A), diaphragm (B) in adult mice and heart in neonatal mouse (C).
RV, right ventricle; LV, left ventricle; IVS, interventricular septum.
Bars: 20 Wm. D and E: The reporter EGFP expression in midsagit-
tal (D) and parasagittal (E) sections of 15.5-dpc embryo. Bar: 500
Wm. F^K: The comparison of localization of EGFP (F and I) and
endogenous Q-SG transcript shown by in situ hybridization using
antisense probe (G and J) and sense probe (H and K). Both EGFP
and Q-SG transcript are expressed in the skeletal muscles (arrow-
heads), whereas EGFP was not detected in the heart in this stage
(double arrowheads). Bar: 100 Wm.
Fig. 3. Temporal expression of 5Pgsg-EGFP transgene in body wall
and limbs during embryogenesis. A: 9.5-dpc whole embryo was ob-
served for EGFP expression (green) with spontaneous £uorescence
(red) observed at excitation and emission wavelengths for rhodamine
£uorescence to image its body. B^E: The sagittal sections through
somite regions of embryos on 10.5 dpc (B), 11.5 dpc (C), 12.5 dpc
(D) and 13.5 dpc (E). Insets in D and E show the EGFP expression
in the tail region in the other sections. Bars: 500 Wm. F^i: Three-di-
mensional images of EGFP £uorescence expression (green) from a
dorsal view were reconstructed from several planes of two-dimen-
sional images using a confocal laser microscope with spontaneous
£uorescence images (red). Upper images, the left forelimb buds of
embryos on 10.5 dpc (F), 11.5 dpc (G), 12.5 dpc (H) and 13.5 dpc
(I); lower images, the left hindlimb buds on 10.5 dpc (f), 11.5 dpc
(g), 12.5 dpc (h) and 13.5 dpc (i). Bars: 100 Wm.
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muscle, rectus abdominis muscle, diaphragm, cutaneous
muscle and tongue, including the epaxial (paraspinal and in-
tercostal) and hepaxial (limb and abdominal) musculature.
The epaxial musculature originates from the dorsal^medial
dermamyotome which is primarily regulated by Myf-5, while
the hepaxial musculature originates from ventral^lateral der-
mamyotome which is primarily regulated by MyoD [13]. The
distribution matched the expression sites of the endogenous Q-
SG transcript in the skeletal muscles by in situ hybridization
(Fig. 2F,G,I,J, arrowheads). However, EGFP was not ex-
pressed in the heart at this embryonic stage (Fig. 2I), although
the endogenous Q-SG transcript was transcribed (Fig. 2J, dou-
ble arrowheads). This may be due to possible enhancers for
heart expression being missing, or due to positional e¡ects of
the transgene in heart expression. Both of two transgenic
mouse lines showed similar patterns in heart expression, so
that a positional e¡ect is less likely and the former possibility
is more likely.
3.3. Temporal expression pattern of the transgene during
embryogenesis
To analyze the temporal expression patterns of the trans-
gene during mouse embryonic development, we used embryos
of the F2 generation and prepared sagittal sections. In the 9.5-
dpc embryo, the reporter EGFP was ¢rst expressed in elon-
gated cells of three rostral somites (arrowhead in Fig. 3A). In
the 10.5-dpc embryo, EGFP was expressed in more than 20
somites (Fig. 3B). On 12.5 dpc, EGFP £uorescence became
intense in the back muscles and intercostal muscles (Fig. 3D).
The rostral-to-caudal progression of the EGFP expression in
the somites during embryogenesis might be related to muscle
formation similar to the observation in the transgenic mice
with myogenin promoter [14]. By comparing these data with
the expression pattern of the endogenous Q-SG transcript dur-
ing mouse embryogenesis examined by RT-PCR (Wakabaya-
shi-Takai et al., unpublished), the transgene expression
mimics the spatiotemporal expression pattern of the Q-SG
transcript in the skeletal muscle.
We also analyzed the temporal expression of the transgene
during embryonic limb muscle formation (Fig. 3F^I). A few
EGFP-positive cells were ¢rst observed in 10.5-dpc embryo in
the proximal part of the forelimb buds (Fig. 3F). On 11.5 dpc,
the EGFP-positive cells spread to the central part of the fore-
limb buds, while EGFP began to be detected in hindlimb buds
(Fig. 3G and g). Most of the EGFP-positive cells in both limb
buds did not appear to be elongated. On 12.5 dpc, the EGFP-
positive cells became ¢lamentous (Fig. 3H,h). In the 13.5-dpc
embryo, EGFP was expressed strongly in the proximal part
(Fig. 3I,i). The onset of the transgene expression in the limb
bud was 1 day later than that in the somites. Other than the
expression in the musculature, an intense EGFP £uorescence
was also observed in the distal ridge of the forelimb and
hindlimb buds (Fig. 3G^h). This may be due to the transient
ectopic expression of the transgene during development, be-
cause we could not detect a signi¢cant signal of Q-SG tran-
script in this region by in situ hybridization or RT-PCR am-
pli¢cation (data not shown) and this expression weakened and
disappeared as ¢nger formation progressed (Fig. 3I).
3.4. Comparison of the expression patterns of transgene and
basic helix loop helix (b-HLH) proteins
By characterization of the Q-SG promoter in C2C12 myo-
cytes, we previously proposed that the b-HLH factors may
work as a trans activator for the Q-SG promoter [7]. We an-
alyzed the relationship between the expression of the trans-
gene and b-HLH transcriptional factors. In the 12.5-dpc em-
bryo, the localization of EGFP and MyoD was primarily the
same except for EGFP expression in the distal ridge of limb
buds (Fig. 4A). Under magni¢cation, some di¡erences be-
tween them were observed in a merged image (Fig. 4B).
MyoD was detected in the weak EGFP £uorescence area in
the abdominal muscles, while the transgene was expressed
strongly in the ¢lamentous myo¢bers with a rather weak
staining of b-HLH factors in the intercostal muscles. These
data suggest that there are di¡erences in timing of expression
between transgene and b-HLH factors. To con¢rm this, we
observed their expression in earlier stage embryos. In the
transverse sections of the 10.5-dpc embryos through the cau-
dal trunk somite, the transgene was observed in a narrow
region throughout the dorsal^ventral extent in myotome. On
the other hand, MyoD and myogenin were observed in dorsal
myotome (Fig. 4C,D). Myf-5 was expressed rather strongly in
the lips of the dermatome (Fig. 4E). The localization of EGFP
did not coincide with that of the b-HLH factors at the cell
Fig. 4. Relationship between the expression of 5Pgsg-EGFP trans-
gene and that of b-HLH transcriptional factors. A: Double-£uores-
cence images of EGFP (green) and anti-MyoD antibody staining
(red) of the sagittal section of 12.5-dpc embryo. EGFP alone was
detected in ridges of limb buds (arrowheads). B: Magni¢ed merged
images of body wall regions shown in a rectangle in A. Arrowheads
indicate the intercostal muscles and double arrowheads indicate the
abdominal muscles. Bar: 500 Wm. C^E: Merged £uorescence images
of EGFP (green) and b-HLH factor antibodies (red) in transverse
sections through caudal trunk somite on 10.5 dpc with anti-MyoD
(C), anti-myogenin (D) and anti-Myf-5 antibodies (E), respectively.
NT, neural tube. Bar: 50 Wm. F^H: Double-£uorescence images of
EGFP (green) and anti-myogenin antibody staining (red) in primary
myocytes cultured for 1 day (F), 3 days (G) and 5 days (H) after
plating the cells.
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level in this stage. Based on these observations, we assumed
that the b-HLH factors appear and pass away rather prior to
the expression of EGFP. To clarify this relation, we made
primary cultures of myocytes from limbs of the neonatal
mice and found that myogenin was strongly expressed, where-
as EGFP was relatively weakly expressed in early stage elon-
gating mononucleated myocytes on the third day of culture
(Fig. 4G). Myogenin expression became weaker in large multi-
nucleated myotubes on the ¢fth day in contrast to the strong
expression of EGFP (Fig. 4H). The expression of b-HLH
factors preceded that of EGFP and this temporally reciprocal
expression strongly supports our previous in vitro observation
that the reporter expression is regulated by b-HLH transcrip-
tional factors during skeletal muscle development.
The above data show that our promoter may be useful for
gene therapy. Recently, gene transfer into SG-de¢cient ani-
mals was attempted [15,16]. In these cases, the cytomegalovi-
rus early promoter and truncated muscle creatine kinase pro-
moter were used for the expression of the transferred gene.
However, the expression pattern of the transferred gene
should reproduce the spatial, temporal and tissue-speci¢c ex-
pression patterns of the endogenous one. In particular, the
formation of the SG complex in the skeletal muscles may be
regulated by the enhancement of K-SG and Q-SG transcrip-
tion. Therefore, the use of the Q-SG promoter seems to be
advantageous for the exogenous SG expression in therapeutic
attempts to restore the SG complex in the striated muscles.
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